Dynamic contrast-enhanced magnetic resonance imaging of canine brain tumors

Veterinary Radiology and Ultrasound

Volumn 51, Issue 2, 2010, Pages 122-129

  Zhao, Qun ^a   Lee, Sunbok ^a   Kent, Marc ^b   Schatzberg, Scott ^b   Platt, Simon ^b  

^a Bioimaging Research Center   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Brain tumor; Dynamic contrast enhanced magnetic resonance imaging (DCE MRI); Pharmacokinetic modeling

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BRAIN TUMOR; DOG; DOG DISEASE; EVALUATION; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANIMALS; BRAIN NEOPLASMS; CONTRAST MEDIA; DOG DISEASES; DOGS; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING;

EID: 77951588482     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2009.01635.x     Document Type: Article

References (58)

1. Platt SR, Scase TJ, Adams V. Vascular endothelial growth factor expression in canine intracranial meningiomas and association with patient survival. J Vet Intern Med 2006, 20:663-668.
2. Dickinson PJRB, Higgins RJ, Leutenegger CM, Bollen AW, Kass PH, LeCouteur RA. Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDGFRα and c-Met in canine primary brain tumours. Vet Comp Oncol 2006, 4:132-140.
3. Koestner A, Bilzer T, Fatzer R, Schulman FY, Summers BA, Van Winkle TJ. Histological classification of tumors of the nervous system of domestic animals. 1999, 1-71. In, WHO, (ed), 2nd ed, Washington, DC, The Armed Forces Institute of Pathology
4. Heidner GL, Kornegay JN, Page RL. Analysis of survival in a retrospective study of 86 dogs with brain tumors. J Vet Intern Med 1991, 5:219-226.
5. Courtay-Cahan C, Platt SR, De Risio L. Preliminary analysis of genomic abnormalities in canine meningiomas. Vet Comp Oncol 2008, 6:182-192.
6. Thomson SA, Kennerly E, Olby N. Microarray analysis of differentially expressed genes of primary tumors in the canine central nervous system. Vet Pathol 2005, 42:550-558.
7. Theon AP, Lecouteur RA, Carr EA. Influence of tumor cell proliferation and sex-hormone receptors on effectiveness of radiation therapy for dogs with incompletely resected meningiomas. J Am Vet Med Assoc 2000, 216:701-707. 684-705
8. Stoica G, Kim HT, Hall DG. Morphology, immunohistochemistry, and genetic alterations in dog astrocytomas. Vet Pathol 2004, 41:10-19.
9. Lipsitz D, Higgins RJ, Kortz GD. Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs. Vet Pathol 2003, 40:659-669.
10. Westworth DR, Dickinson PJ, Vernau W. Choroid plexus tumors in 56 dogs (1985-2007). J Vet Intern Med 2008, 22:1157-1165.
11. Patnaik AK, Kay WJ, Hurvitz AI. Intracranial meningioma: a comparative pathologic study of 28 dogs. Vet Pathol 1986, 23:369-373.
12. Montoliu P, Anor S, Vidal E. Histological and immunohistochemical study of 30 cases of canine meningioma. J Comp Pathol 2006, 135:200-207.
13. Rossmeisl JH, Duncan RB, Huckle WR. Expression of vascular endothelial growth factor in tumors and plasma from dogs with primary intracranial neoplasms. Am J Vet Res 2007, 68:1239-1245.
14. Vandevelde M, Fankhauser R, Luginbuhl H. Immunocytochemical studies in canine neuroectodermal brain tumors. Acta Neuropathol 1985, 66:111-116.
15. Sturges BK, Dickinson PJ, Bollen AW. Magnetic resonance imaging and histological classification of intracranial meningiomas in 112 dogs. J Vet Intern Med 2008, 22:586-595.
16. Snyder JM, Shofer FS, Van Winkle TJ. Canine intracranial primary neoplasia: 173 cases (1986-2003). J Vet Intern Med 2006, 20:669-675.
17. Kraft SL, Gavin PR, DeHaan C. Retrospective review of 50 canine intracranial tumors evaluated by magnetic resonance imaging. J Vet Intern Med 1997, 11:218-225.
18. Graham JP, Newell SM, Voges AK. The dural tail sign in the diagnosis of meningiomas. Vet Radiol Ultrasound 1998, 39:297-302.
19. Kraft SL, Gavin PR. Intracranial neoplasia. Clin Tech Small Anim Pract 1999, 14:112-123.
20. Polizopoulou ZS, Koutinas AF, Souftas VD. Diagnostic correlation of CT-MRI and histopathology in 10 dogs with brain neoplasms. J Vet Med A Physiol Pathol Clin Med 2004, 51:226-231.
21. Cherubini GB, Mantis P, Martinez TA. Utility of magnetic resonance imaging for distinguishing neoplastic from non-neoplastic brain lesions in dogs and cats. Vet Radiol Ultrasound 2005, 46:384-387.
22. Engelhard HH. Progress in the diagnosis and treatment of patients with meningiomas. Part I: diagnostic imaging, preoperative embolization. Surg Neurol 2001, 55:89-101.
23. Suzuki Y, Sugimoto T, Shibuya M. Meningiomas: correlation between MRI characteristics and operative findings including consistency. Acta Neurochir (Wienheim) 1994, 129:39-46.
24. Dickinson PJ, Sturges BK, Higgins RJ. Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors. Vet Pathol 2008, 45:131-139.
25. Barrett T, Brechbiel M, Bernardo M. MRI of tumor angiogenesis. J Magn Reson Imaging 2007, 26:235-249.
26. Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001, 56:607-620.
27. Daldrup-Link H, Rydland J, Helbich T. Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial. Radiology 2003, 229:885-892.
28. Morakkabati N, Leutner C, Schmiedel A. Breast MR imaging during or soon after radiation therapy. Radiology 2003, 229:893-901.
29. Tofts P. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997, 7:91-101.
30. Tofts P, Brix G, Buckley D. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999, 10:223-232.
31. Brix G, Semmler W, Port R. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991, 15:621-628.
32. Larsson H, Stubgaard M, Frederiksen J. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990, 16:117-131.
33. Workie D, Dardzinski B, Graham T. Quantification of dynamic contrast-enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling. Magn Reson Imaging 2004, 22:1201-1210.
34. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999, 10:254-259.
35. Seymour H, Koenig RDB. Determinants of proton relaxation rates in tissue. Magn Reson Med 1984, 1:437-449.
36. Winfried AW, Christiane KK. 3.0T neuroimaging: technical considerations and clinical applications. Neuroimaging Clinics North Am 2006, 16:217-228.
37. Carroll TJ, Rowley HA, Haughton VM. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 2003, 227:593-600.
38. Fritz-Hansen T, Rostrup E, Larsson HB. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996, 36:225-231.
39. Hoffmann U, Brix G, Knopp M. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995, 33:506-514.
40. http://imaging.cancer.gov/reportsandpublications/ReportsandPresentations/MagneticResonance, National Cancer Institute., DCE-MRI group consensus recommendations. NCI CIP MR Workshop on Translational Research in Cancer -Tumor Response. Available at
41. Falzone C, Rossi F, Calistri M. Contrast-enhanced fluid-attenuated inversion recovery vs. contrast-enhanced spin echo T1-weighted brain imaging. Vet Radiol Ultrasound 2008, 49:333-338.
42. Westworth DR, Dickinson PJ, Vernau W. Choroid plexus tumors in 56 dogs (1985-2007). J Vet Intern Med 2008, 22:1157-1165.
43. Mellema LM, Samii VF, Vernau KM. Meningeal enhancement on magnetic resonance imaging in 15 dogs and 3 cats. Vet Radiol Ultrasound 2002, 43:10-15.
44. Tidwell AS, Jones JC. Advanced imaging concepts: a pictorial glossary of CT and MRI technology. Clin Tech Small Anim Pract 1999, 14:65-111.
45. Runge VM, Muroff LR, Wells JW. Principles of contrast enhancement in the evaluation of brain diseases: an overview. J Magn Reson Imaging 1997, 7:5-13.
46. Kangasniemi M, Stafford RJ, Price RE. Dynamic gadolinium uptake in thermally treated canine brain tissue and experimental cerebral tumors. Invest Radiol 2003, 38:102-107.
47. Graham JP, Roberts GD, Newell SM. Dynamic magnetic resonance imaging of the normal canine pituitary gland. Vet Radiol Ultrasound 2000, 41:35-40.
48. Heilmann M, Kiessling F, Enderlin M. Determination of pharmacokinetic parameters in DCE MRI: consequence of nonlinearity between contrast agent concentration and signal intensity. Invest Radiol 2006, 41:536-543.
49. Roberts C, Issa B, Stone A. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006, 23:554-563.
50. Buadu LD, Murakami J, Murayama S. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996, 200:639-649.
51. Buckley DL, Drew PJ, Mussurakis S. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 1997, 7:461-464.
52. Hawighorst H, Knapstein PG, Weikel W. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997, 57:4777-4786.
53. Stomper PC, Winston JS, Herman S. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 1997, 45:39-46.
54. Tynninen O, Aronen HJ, Ruhala M. MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. Invest Radiol 1999, 34:427-434.
55. Ludemann L, Hamm B, Zimmer C. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. Magn Reson Imaging 2000, 18:1201-1214.
56. Ludemann L, Grieger W, Wurm R. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 2001, 11:1231-1241.
57. Roberts HC, Roberts TP, Bollen AW. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 2001, 8:384-391.
58. Roberts HC, Roberts TP, Brasch RC. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. Am J Neuroradiol 2000, 21:891-899.